PFSA — Profusa, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1859807 ·
Last close
$0.35
Market Cap
$210.8K
52W High
$1515.00
52W Low
$0.32
ADV30
2,063,280
Next earnings
—
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -2,545,000 -8,755,000 1,042,000 719,000 28,169,000
Mar 2026 0 — -4,006,000 -3,456,000 862,000 375,000 29,060,000
Dec 2025 0 — -3,570,000 -8,567,000 3,775,000 1,778,000 30,433,000
Sep 2025 0 — -21,709,000 -22,192,000 4,250,000 3,009,000 38,210,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-20,330,000
Investing CF
$-936,000
Financing CF
$21,946,000
CapEx
$-78,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6143.98
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-172,992,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-42,737,000
Pretax Income TTM
$-42,970,000
Interest Exp TTM
$233,000
Analysts
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -27,706,000 -35,823,000 3,780,000 30,433,000 -26,658,000 -16,248,000
Dec 2024 0 -4,500,000 -9,230,000 3,073,000 122,278,000 -119,205,000 -2,066,000
Dec 2023 0 -6,070,000 -10,281,000 1,893,000 111,889,000 -109,996,000 -4,402,000
Dec 2022 0 -9,443,000 -20,217,000 1,031,000 100,802,000 -99,771,000 -7,702,000

TTM Snapshot

Revenues TTM
$-95,084
NetIncome TTM
$-38,717,214
OpCashFlow TTM
—
Assets (Latest)
$1,042,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
FEED ENvue Medical, Inc. $235.5K $0.25 —
GCTK Glucotrack, Inc. $149.3K $0.19 —
SIGY Sigyn Therapeutics, Inc. $145.2K $0.03 —
PREM Premier Air Charter Holdings Inc. $393.6K $0.01 —
ODYY Odyssey Health, Inc. $771.5K $0.01 —

News headlines (Yahoo Finance, 1h cache)

Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
2026-11-12 12:30 · Yahoo
Profusa Receives ISO 13485:2016 Certificate from GMED
2026-10-15 10:30 · Yahoo
Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark
2026-09-24 15:01 · Yahoo
Profusa, Inc. Receives Nasdaq Compliance Determination
2026-09-15 10:00 · Yahoo
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
2026-08-31 12:50 · Yahoo
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens
2026-08-20 14:49 · Yahoo
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
2026-08-20 12:30 · Yahoo
Profusa vies for potential G3 Vision Labs acquisition
2026-08-03 11:17 · Yahoo
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes
2026-07-27 14:38 · Yahoo
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
2026-07-27 10:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.